Pulmonx Corporation
(LUNG)
undefined
undefined%
At close: undefined
5.70
-14.67%
Pre-market Jan 07, 2025, 04:42 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -60.84M | -58.92M | -48.66M | -32.23M | -20.70M | -18.48M |
| Depreciation & Amortization | 1.55M | 1.51M | 867.00K | 483.00K | 365.00K | 270.00K |
| Stock-Based Compensation | 22.10M | 16.45M | 10.53M | 3.20M | 364.00K | 366.00K |
| Other Working Capital | -27.00K | -1.43M | 957.00K | -1.79M | 2.21M | 632.00K |
| Other Non-Cash Items | 2.14M | 2.85M | 2.47M | 5.46M | 864.00K | 36.00K |
| Deferred Income Tax | n/a | 49.00K | 1.26M | -2.76M | 746.00K | 936.00K |
| Change in Working Capital | -2.56M | -7.01M | -7.85M | -4.79M | -2.40M | -1.52M |
| Operating Cash Flow | -37.61M | -45.08M | -41.39M | -30.63M | -20.77M | -18.39M |
| Capital Expenditures | -807.00K | -1.32M | -3.67M | -911.00K | -720.00K | -316.00K |
| Acquisitions | n/a | 2.91M | 42.58M | n/a | 13.51M | 16.00K |
| Purchase of Investments | -46.20M | -47.19M | -52.58M | n/a | -21.45M | n/a |
| Sales Maturities Of Investments | 45.00M | 44.28M | 10.00M | 13.61M | 7.94M | 500.00K |
| Other Investing Acitivies | n/a | -2.91M | -42.58M | 13.61M | -13.51M | 16.00K |
| Investing Cash Flow | -2.01M | -4.22M | -46.26M | 12.69M | -14.23M | 200.00K |
| Debt Repayment | 19.91M | -87.00K | n/a | 32.99M | 6.00M | 12.00M |
| Common Stock Repurchased | 1.18M | -27.00K | -26.00K | n/a | -12.00K | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 1.49M | 2.51M | 4.46M | 446.00K | 39.62M | 114.00K |
| Financial Cash Flow | 21.40M | 2.47M | 4.46M | 234.83M | 45.62M | 12.11M |
| Net Cash Flow | -18.18M | -46.74M | -83.08M | 217.03M | 10.64M | -5.93M |
| Free Cash Flow | -38.42M | -46.40M | -45.06M | -31.54M | -21.48M | -18.71M |